ArticleBlood advances2018

Comment on model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients.

Stefan Willmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.